首页 | 本学科首页   官方微博 | 高级检索  
     

通过Fas-FasL途径体外清除小鼠同种异体反应性T细胞
引用本文:刘凌波,邹萍,徐之良,胡中波,陈燕,宋善俊. 通过Fas-FasL途径体外清除小鼠同种异体反应性T细胞[J]. 中华血液学杂志, 2002, 23(4): 187-190
作者姓名:刘凌波  邹萍  徐之良  胡中波  陈燕  宋善俊
作者单位:1. 430022,武汉,华中科技大学同济医学院附属协和医院血液病学研究所
2. 430022,武汉,武汉大学人民医院小儿科
基金项目:国家自然科学基金资助项目 ( 39770 76 7)
摘    要:目的 通过Fas Fas配体 (FasL)途径清除小鼠同种异体反应性T细胞 (ARTC) ,为减轻异基因骨髓移植 (allo BMT)后的移植物抗宿主病探索新的手段。方法 用磁性细胞分离系统分离BALB c小鼠 (H 2 d)Sca 1+早期造血细胞 (HC) ,然后借助逆转录病毒基因转移技术对其转染外源小鼠FasL(mFasL)cDNA基因 ;扩增 1周后与异基因BAC小鼠 (H 2 d ×b)脾细胞进行单向混合淋巴细胞培养(OWMLC) 6d ,观察处理后的BAC小鼠脾细胞对Na251 CrO4标记的BALB c小鼠脾细胞的杀伤作用。结果 成功分离出BALB c小鼠Sca 1+HC ,纯度为 (89.0± 6 .1) %。BAC小鼠脾细胞与转染外源mFasL的BALB cHC以 1∶5比例共培养 6d后 ,对BALB c源脾细胞杀伤率在不同效、靶比例时均呈显著降低 (P<0 .0 1)。结论 体外反应中 ,转染外源mFasLcDNA并高表达的早期HC可清除针对自身MHC抗原的ARTC。

关 键 词:Fas-FasL途径 同种异体反应性T细胞 Fas配体 Fas抗原 异基因骨髓移植 移植物抗宿主病
修稿时间:2001-06-29

Selected elimination of mouse alloreactive T cells by Fas-FasL passway
LIU Lingbo ,ZOU Ping,XU Zhiliang,HU Zhongbo,CHEN Yan,SONG Shanjun. Selected elimination of mouse alloreactive T cells by Fas-FasL passway[J]. Chinese Journal of Hematology, 2002, 23(4): 187-190
Authors:LIU Lingbo   ZOU Ping  XU Zhiliang  HU Zhongbo  CHEN Yan  SONG Shanjun
Affiliation:Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Abstract:OBJECTIVE: To explore a new method of alleviating graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation (allo-BMT) through selected elimination of mouse alloreactive T cells (ARTC) by Fas-Fas ligand (FasL) passway. METHODS: The Sca-1(+) early hematopoietic cells (EHCs) were isolated from BALB/c mouse (H-2(d)) bone marrow mononuclear cells (BMMC) by using a high gradient magnetic cell sorting system (MACS), then transferred with exogenous mouse FasL (mFasL) gene by retroviral gene transfecting technique. Afterward the transduced EHCs were expanded in vitro for one week followed by coculture with the spleen cells from BAC mouse (H-2(d) x b) as one-way mixed lymphocyte culture (OWMLC) for 6 days, then the cytotoxicity of treated BAC mouse spleen cells against Na(2)(51)CrO(4) labelling spleen cells from BALB/c mouse was observed. RESULTS: The Sca-1(+) EHCs were successfully isolated by MACS, with a purity of (89.0 +/- 6.1)%. After transferred with exogenous mFasL gene and expanded for one week, the transferred EHCs in the 6 day OWMLC with the spleen cells from BAC mouse at a ratio of five to one resulted in an obvious inhibition of the BAC mouse spleen cells cytotoxicity against the BALB/c mouse spleen cell at different effector/target ratios as compared to the control group (P < 0.01). CONCLUSION: The higher exogenous mFasL-expressing mouse EHCs can deplete ARTC against their own major histocompatibility complex (MHC) antigens in vitro.
Keywords:Fas ligand  Fas antigen  Bone marrow transplantation  Graft versus host disease
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号